Topics

Human medicines European public assessment report (EPAR): Desloratadine Actavis, desloratadine, Rhinitis, Allergic, Perennial,Urticaria,Rhinitis, Allergic, Seasonal, Date of authorisation: 13/01/2012, Revision: 12, Status: Authorised

10:17 EDT 11 Oct 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Desloratadine Actavis, desloratadine, Rhinitis, Allergic, Perennial,Urticaria,Rhinitis, Allergic, Seasonal, Date of authorisation: 13/01/2012, Revision: 12, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Desloratadine Actavis, desloratadine, Rhinitis, Allergic, Perennial,Urticaria,Rhinitis, Allergic, Seasonal, Date of authorisation: 13/01/2012, Revision: 12, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Desloratadine Actavis, desloratadine, Rhinitis, Allergic, Perennial,Urticaria,Rhinitis, Allergic, Seasonal, Date of authorisation: 13/01/2012, Revision: 12, Status: Authorised"

Quick Search

Relevant Topic

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...